- Home
- DOCS vs BRKR Comparison
DOCS vs BRKR Comparison
Compare DOCS & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCS
- BRKR
- Stock Information
- Founded
- DOCS 2010
- BRKR 1991
- Country
- DOCS United States
- BRKR United States
- Employees
- DOCS 827
- BRKR N/A
- Industry
- DOCS Retail: Computer Software & Peripheral Equipment
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- DOCS Technology
- BRKR Industrials
- Exchange
- DOCS Nasdaq
- BRKR Nasdaq
- Market Cap
- DOCS 10.4B
- BRKR 9.2B
- IPO Year
- DOCS 2021
- BRKR 2000
- Fundamental
- Price
- DOCS $55.53
- BRKR $60.07
- Analyst Decision
- DOCS Hold
- BRKR Buy
- Analyst Count
- DOCS 16
- BRKR 13
- Target Price
- DOCS $52.69
- BRKR $76.00
- AVG Volume (30 Days)
- DOCS 1.9M
- BRKR 1.4M
- Earning Date
- DOCS 02-06-2025
- BRKR 02-11-2025
- Dividend Yield
- DOCS N/A
- BRKR 0.33%
- EPS Growth
- DOCS 50.58
- BRKR N/A
- EPS
- DOCS 0.87
- BRKR 2.06
- Revenue
- DOCS $516,849,000.00
- BRKR $3,241,300,000.00
- Revenue This Year
- DOCS $15.79
- BRKR $15.23
- Revenue Next Year
- DOCS $10.34
- BRKR $7.52
- P/E Ratio
- DOCS $63.47
- BRKR $29.14
- Revenue Growth
- DOCS 15.29
- BRKR 15.00
- 52 Week Low
- DOCS $22.96
- BRKR $48.07
- 52 Week High
- DOCS $61.75
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- DOCS 56.25
- BRKR 52.88
- Support Level
- DOCS $49.01
- BRKR $54.60
- Resistance Level
- DOCS $57.15
- BRKR $64.64
- Average True Range (ATR)
- DOCS 1.87
- BRKR 2.91
- MACD
- DOCS -0.18
- BRKR -0.16
- Stochastic Oscillator
- DOCS 80.15
- BRKR 54.48
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.